Clinical Trial Update: Long-Term Follow-up of Tandem High-Dose Therapy With Peripheral Blood Stem Cell for Adults With High-Risk Age-Adjusted IPI Aggressive Non-Hodgkin's Lymphomas [Phase 2]

View source ↗

Summary

Long-term follow-up results from a Phase 2 trial evaluating tandem high-dose chemotherapy with autologous peripheral blood stem cell rescue for adults with high…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Snippet

Sponsor: French Innovative Leukemia Organisation | Conditions: Lymphoma | Phase 2 | Status: COMPLETED